Study on Indomethacin-responsive Headaches
Sponsor
Anne Ducros (Other)
Overall Status
Unknown status
CT.gov ID
NCT03967483
Collaborator
(none)
100
24
Study Details
Study Description
Brief Summary
Description of modalities concerning the patient care of headaches sensible to indometacine.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
Detailed Description
Description of clinical profile, treatment of crisis and background treatment
Study Design
Study Type:
Observational
Anticipated Enrollment
:
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Non Interventional Study on Indomethacin-responsive Headaches
Anticipated Study Start Date
:
Jun 1, 2019
Anticipated Primary Completion Date
:
Jun 1, 2020
Anticipated Study Completion Date
:
Jun 1, 2021
Outcome Measures
Primary Outcome Measures
- Description of headaches sensible to indometacine [24 monthes]
Description of the clinical cases with headaches sensible to indometacine according to the type of headaches.
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
patient with a diagnosis of migraine with or without aura, or trigemino-autosomic headaches or other primary headaches
-
patient who are taking indometacine
-
patient with written consent form
Exclusion Criteria:
-
patient under 18 years
-
pregnant woman or breastfeeding patient
-
patient who refuses to participate
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Anne Ducros
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Anne Ducros,
Pr,
French Society for the Study of Migraine Headache
ClinicalTrials.gov Identifier:
NCT03967483
Other Study ID Numbers:
- 2019-A00406-51
First Posted:
May 30, 2019
Last Update Posted:
May 30, 2019
Last Verified:
May 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: